Withdrawal of Prexige (lumiracoxib)

15 August 2007

Cox 2 inhibitor, Prexige (lumiracoxib) is no longer available in Australia. Novartis Pharmaceuticals Australia has withdrawn all strengths of Prexige (lumiracoxib) following cancellation of its registration by the Therapeutic Goods Administration (TGA).

The listing for Prexige (lumiracoxib) tablets in the Schedule of Pharmaceutical Benefits will be removed as soon as possible, on 1 October 2007.

For further information regarding the withdrawal of Prexige (lumiracoxib) visit the TGA website.